Literature DB >> 16049352

The role of oxidative stress in diabetic complications.

Dana M Niedowicz1, David L Daleke.   

Abstract

The morbidity and mortality associated with diabetes is the result of the myriad complications related to the disease. One of the most explored hypotheses to explain the onset of complications is a hyperglycemia-induced increase in oxidative stress. Reactive oxygen species (ROS) are produced by oxidative phosphorylation, nicotinamide adenine dinucleotide phosphate oxidase (NADPH), xanthine oxidase, the uncoupling of lipoxygenases, cytochrome P450 monooxygenases, and glucose autoxidation. Once formed, ROS deplete antioxidant defenses, rendering the affected cells and tissues more susceptible to oxidative damage. Lipid, DNA, and protein are the cellular targets for oxidation, leading to changes in cellular structure and function. Recent evidence suggests ROS are also important as second messengers in the regulation of intracellular signaling pathways and, ultimately, gene expression. This review explores the production of ROS and the propagation and consequences of oxidative stress in diabetes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16049352     DOI: 10.1385/CBB:43:2:289

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  75 in total

1.  Epidermis-type lipoxygenase 3 regulates adipocyte differentiation and peroxisome proliferator-activated receptor gamma activity.

Authors:  Philip Hallenborg; Claus Jørgensen; Rasmus K Petersen; Søren Feddersen; Pedro Araujo; Patrick Markt; Thierry Langer; Gerhard Furstenberger; Peter Krieg; Arjen Koppen; Eric Kalkhoven; Lise Madsen; Karsten Kristiansen
Journal:  Mol Cell Biol       Date:  2010-06-07       Impact factor: 4.272

2.  Association of the C47T polymorphism in SOD2 with diabetes mellitus and diabetic microvascular complications: a meta-analysis.

Authors:  C Tian; S Fang; X Du; C Jia
Journal:  Diabetologia       Date:  2010-12-22       Impact factor: 10.122

3.  The role of oxidative stress and antioxidants in diabetic complications.

Authors:  Fatmah A Matough; Siti B Budin; Zariyantey A Hamid; Nasar Alwahaibi; Jamaludin Mohamed
Journal:  Sultan Qaboos Univ Med J       Date:  2012-02-07

4.  A brief review of in vitro models of diabetic neuropathy.

Authors:  Namita G Hattangady; Medha S Rajadhyaksha
Journal:  Int J Diabetes Dev Ctries       Date:  2009-10

5.  Comparison of mechanisms involved in impaired vascular reactivity between high sucrose and high fat diets in rats.

Authors:  Karen L Sweazea; Mateja Lekic; Benjimen R Walker
Journal:  Nutr Metab (Lond)       Date:  2010-06-04       Impact factor: 4.169

6.  NADPH Oxidase versus Mitochondria-Derived ROS in Glucose-Induced Apoptosis of Pericytes in Early Diabetic Retinopathy.

Authors:  Nik M Mustapha; Joanna M Tarr; Eva M Kohner; Rakesh Chibber
Journal:  J Ophthalmol       Date:  2010-06-28       Impact factor: 1.909

7.  The initiation of free radical peroxidation of low-density lipoproteins by glucose and its metabolite methylglyoxal: a common molecular mechanism of vascular wall injure in atherosclerosis and diabetes.

Authors:  Vadim Lankin; Galina Konovalova; Alla Tikhaze; Konstantin Shumaev; Elena Kumskova; Margus Viigimaa
Journal:  Mol Cell Biochem       Date:  2014-07-05       Impact factor: 3.396

Review 8.  Diabetes and Its Effect on Bone and Fracture Healing.

Authors:  Hongli Jiao; E Xiao; Dana T Graves
Journal:  Curr Osteoporos Rep       Date:  2015-10       Impact factor: 5.096

9.  Genetic polymorphisms in genes encoding antioxidant enzymes are associated with diabetic retinopathy in type 1 diabetes.

Authors:  Tinka Hovnik; Vita Dolzan; Natasa Ursic Bratina; Katarina Trebusak Podkrajsek; Tadej Battelino
Journal:  Diabetes Care       Date:  2009-09-14       Impact factor: 17.152

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.